Nyt1 dags konference

Symposium on medical cannabis: From plant to patient

Kontakt os på tlf. 7220 3000 eller skriv til  kurser@teknologisk.dk for at høre mere.

Ingen planlagte afholdelser.
DKK  500
ekskl. moms
Nr. 90813 P
9 anmeldelser

Medical cannabis has been developing rapidly to a significant industry in Denmark. Since the launch of a four-year pilot period, several companies were established along the value chain from breeding, production, processing and development of medical products.

The production and export of medical cannabis will be governed by a permanent framework as of 2022. Development of the industry will continue to accelerate as exports have started. The first movers are scaling up while new entrants to the industry attempt to establish themselves in this dynamic industry. Building on a strong regulatory framework that encourages high standards and open competition, Denmark is establishing a leading position that draws on traditional strengths in biotechnology and applied research.

Yet as much as the permanent framework provides stability for the industry, a new threat emerges from lower-cost production elsewhere in Europe (and beyond), commodification, rising standards, stops and starts along the road towards commercial operations, and – most important of all – a continued demand for rigorous data on the effectiveness of medical cannabis.

The solution to these threats depend on research and innovation.

Partnerships across the ecosystem are emerging in areas like breeding, sustainable production methods, and clinical research, while more partnerships are needed to close gaps in knowledge. Denmark is an international powerhouse in the pharma and advanced horticulture sector and has a well-established framework for public-private partnerships in research. There are good examples of collaboration between value chain partners, but more integration is needed across the entire ecosystem to meet the demands of the industry.

This year’s event draws on the newest knowledge of breeding, production, processing and clinical studies. Supported by the main question: How does collaboration create innovation?

Anmeldelser af Symposium on medical cannabis: From plant to patient

Fremragende Baseret på 9 anmeldelser
Meget godt
Mindre godt
Ikke godt

Conference dinner

The conference ends at 16.30. If you would like to participate in the following conference dinner, please choose the option 'conference dinner' under registration. The dinner costs 350 DKK.

About the hosts

Invest in Denmark – National investment promotion agency under the Ministry of Foreign Affairs, Invest in Denmark has been actively involved in attracting medical cannabis investments into the Danish ecosystem as support for the development scheme, including some of the largest cultivators in the world.

Danish Technological Institute (GTS) transferring science to industry. For more than 100 years the Institute is supporting the Danish industry with new technology and innovations. Center for Plant Technology has the focus on plant production, breeding and pathogens.


Få ny inspiration til din kompetence­udvikling

Unikke tilbud, relevante artikler og nyt om vores kurser og uddannelser.

Indtast venligst et validt navn
Tilmelder nyhedsbrev
Tak for din tilmelding
Teknisk fejl

Der er desværre en systemfejl på nuværende tidspunkt. Du kan alternativt skrive en mail til data@teknologisk.dk